Found "HTA": 300 results
Sort by
Last updated

Guest Blog: Reflections on PMAC 2020 from a Canadian Student Perspective

On January 28, 2020, PMAC 2020: Accelerating the Progress Towards UHC officially started with side meetings, with one of the very first ones hosted by Health Intervention and Technology Assessment Program (HITAP), titled “Attain & Sustain Health Gains: Incorporating Value-For-Money in the Univer

HITAP Webinar: Introducing the Whole Disease Modelling Approach

As economic evaluation methods are constantly changing and developing, it is important to stay abreast of the latest developments so that any beneficial new techniques are utilised, where possible, to maximise the public health impact of health economics and health technology assessment (HT

At 4500 miles apart, Thailand joins the Kenyan UHC Fund Taskforce Meeting

On 21st September 2020, HITAP joined representatives of the Ministry of Public Health (MOPH) Thailand and the National Health Security Office (NHSO) at the Kenyan Universal Health Coverage (UHC) Fund Taskforce meeting chaired by Mr. Geoffrey Malombe from National Treasury and Dr. Mercy Mwangangi, Ch

HITAP WEBINAR: EQUITY & DISTRIBUTIONAL COST-EFFECTIVENESS ANALYSIS

Inequalities of health exist across the globe, between genders, socioeconomic groups, ethnicities, geographic regions, and many other characteristics. Health interventions rarely, if ever, have a uniform impact on all the groups that are eligible to receive them, yet most economic evaluations only q

Webinar on Analysing the Economics of COVID-19: Methodological Challenges and Data Gaps

COVID-19 has dominated headlines for over a year now and that doesn’t look likely to change in 2021. Health economic and epidemiological modelling has played a key and well-publicised role in informing policymaking decisions across the globe in response to the COVID-19 pandemic. These models and pro

HTAsiaLink Annual Conference 2022: Abstracts and Pre-Conference Session Proposals Submissions are Now Closed!

Beyond expectations – More than 100 abstracts and almost 20 pre-conference session proposals are submitted and will be carefully reviewed by the Scientific Committee. Thank you for your interest and contribution to our network!Results of the review will be sent to the author/s by 30 September 2022 v

The challenges in reimbursement decisions for innovative high-cost drugs: Thailand’s effort to expand drug access

The decision-making challenge for reimbursing costly innovative drugs Health technology assessment (HTA) is a multi-disciplinary approach crucial to the decision-making framework for drug reimbursements. It gives evidence of the drug’s cost-effectiveness and affordability to help policymakers decide

A Tribute to Dr. David Banta: the Pioneer of HTA

Since its inception, health technology assessment (HTA) has assisted governments across the world through evidence-informed health resources allocation and it all begins at the Office of Technology Assessment (OTA), United States Congress led by Dr. David Banta.This video is a tribute to Dr. David B

What the Role of HTA in Healthcare Systems should be after COVID-19?

The COVID-19 pandemic has transformed healthcare systems around the world. One of important issues that COVID-19 clearly emphasizes is the critical importance of information on health technology and policy. Handling the COVID-19 pandemic was difficult at the beginning because humanity all faced the

Real-Word Evidence: How Does It Make HTA More Realistic? Is It Appropriate to Use?

Why do we need to make health technology assessment (HTA) more realistic? Is HTA not realistic nowadays? The answers can be both YES and NO.HTA is a form of research for synthesising data to evaluate properties, effects, and impacts of health interventions and technology in diffe
10 / Page